JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halpern, B. S.
Right arrow Articles by Czernin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halpern, B. S.
Right arrow Articles by Czernin, J.
Journal of Nuclear Medicine Vol. 46 No. 4 603-607
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Optimizing Imaging Protocols for Overweight and Obese Patients: A Lutetium Orthosilicate PET/CT Study

Benjamin S. Halpern, MD1, Magnus Dahlbom, PhD1, Martin A. Auerbach, MD1, Christiaan Schiepers, MD, PhD1, Barbara J. Fueger, MD1, Wolfgang A. Weber, MD1, Daniel H.S. Silverman, MD, PhD1, Osman Ratib, MD, PhD2 and Johannes Czernin, MD1

1 Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine, Los Angeles, California
2 Department of Radiological Sciences, UCLA David Geffen School of Medicine, Los Angeles, California

High photon attenuation and scatter in obese patients affect image quality. The purpose of the current study was to optimize lutetium orthosilicate (LSO) PET image acquisition protocols in patients weighing ≥91 kg (200 lb). Methods: Twenty-five consecutive patients (16 male and 9 female) weighing ≥91 kg (200 lb; range, 91–168 kg [200–370 lb]) were studied with LSO PET/CT. After intravenous injection of 7.77 MBq (0.21 mCi) of 18F-FDG per kilogram of body weight, PET emission scans were acquired for 7 min/bed position. Single-minute frames were extracted from the 7 min/bed position scans to reconstruct 1–7 min/bed position scans for each patient. Three reviewers independently analyzed all 7 reconstructed whole-body images of each patient. A consensus reading followed in cases of disagreement. Thus, 175 whole-body scans (7 per patient) were analyzed for number of hypermetabolic lesions. A region-of-interest approach was used to obtain a quantitative estimate of image quality. Results: Fifty-nine hypermetabolic lesions identified on 7 min/bed position scans served as the reference standard. Interobserver concordance increased from 64% for 1 min/bed position scans to 70% for 3 min/bed position scans and 78% for 4 min/bed position scans. Concordance rates did not change for longer imaging durations. Region-of-interest analysis revealed that image noise decreased from 21% for 1 min/bed position scans to 14%, 13%, and 11% for, respectively, 4, 5, and 7 min/bed position scans. When compared with the reference standard, 14 lesions (24%) were missed on 1 min/bed position scans but only 2 (3%) on 4 min/bed position scans. Five minute/bed position scans were sufficient to detect all lesions identified on the 7 min/bed position scans. Conclusion: Lesion detectability and reader concordance peaked for 5 min/bed position scans, with no further diagnostic gain achieved by lengthening the duration of PET emission scanning. Thus, 5 min/bed position scans are sufficient for optimal lesion detection with LSO PET/CT in obese patients.

Key Words: lutetium orthosilicate • PET/CT • molecular imaging


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
Y. Masuda, C. Kondo, Y. Matsuo, M. Uetani, and K. Kusakabe
Comparison of Imaging Protocols for 18F-FDG PET/CT in Overweight Patients: Optimizing Scan Duration Versus Administered Dose
J. Nucl. Med., June 1, 2009; 50(6): 844 - 848.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. R. Benz, J. Czernin, M. S. Allen-Auerbach, W. D. Tap, S. M. Dry, D. Elashoff, K. Chow, V. Evilevitch, J. J. Eckardt, M. E. Phelps, et al.
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas
Clin. Cancer Res., April 15, 2009; 15(8): 2856 - 2863.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. Imani, V. G. Agopian, M. S. Auerbach, M. A. Walter, F. Imani, M. R. Benz, R. A. Dumont, C. K. Lai, J. G. Czernin, and M. W. Yeh
18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
J. Nucl. Med., April 1, 2009; 50(4): 513 - 519.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. R. Benz, M. S. Allen-Auerbach, F. C. Eilber, H. J.J. Chen, S. Dry, M. E. Phelps, J. Czernin, and W. A. Weber
Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas
J. Nucl. Med., October 1, 2008; 49(10): 1579 - 1584.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
S. Belakhlef, C. Church, A. Hays, R. Fraser, and S. Lakhanpal
Quantitative Assessment of the Influence of Location, Internal Temperature, Idle Time, and Normalization on the Sensitivity of a Mobile PET/CT Scanner
J. Nucl. Med. Technol., September 1, 2008; 36(3): 147 - 150.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Kawano, E. Ohtake, and T. Inoue
Deep-Inspiration Breath-Hold PET/CT of Lung Cancer: Maximum Standardized Uptake Value Analysis of 108 Patients
J. Nucl. Med., August 1, 2008; 49(8): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Evilevitch, W. A. Weber, W. D. Tap, M. Allen-Auerbach, K. Chow, S. D. Nelson, F. R. Eilber, J. J. Eckardt, R. M. Elashoff, M. E. Phelps, et al.
Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas
Clin. Cancer Res., February 1, 2008; 14(3): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
A. Belakhlef, C. Church, R. Fraser, and S. Lakhanpal
Sensitivity and Daily Quality Control of a Mobile PET/CT Scanner Operating in 3-Dimensional Mode
J. Nucl. Med. Technol., December 1, 2007; 35(4): 229 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
C. D. Botkin and M. M. Osman
Prevalence, Challenges, and Solutions for 18F-FDG PET Studies of Obese Patients: A Technologist's Perspective
J. Nucl. Med. Technol., June 1, 2007; 35(2): 80 - 83.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Allen-Auerbach, K. Yeom, J. Park, M. Phelps, and J. Czernin
Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
J. Nucl. Med., February 1, 2006; 47(2): 298 - 301.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. C. Watson, M. E. Casey, B. Bendriem, J. P. Carney, D. W. Townsend, S. Eberl, S. Meikle, and F. P. DiFilippo
Optimizing Injected Dose in Clinical PET by Accurately Modeling the Counting-Rate Response Functions Specific to Individual Patient Scans
J. Nucl. Med., November 1, 2005; 46(11): 1825 - 1834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.